![Dmitri V. Lissin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dmitri V. Lissin
Technik-/Wissenschafts-/F&E-Leiter bei
SCILEX HOLDING COMPANY
Profil
Dr. Dmitri V.
Lissin, MD, is a Chief Medical Officer & Senior Vice President at Scilex, Inc., a Chief Medical Officer & Senior Vice President at Scilex Holding Co., a Chief Medical Officer & Senior Vice President at Semnur Pharmaceuticals, Inc. and a Director & Chief Medical Officer at Semnur, Inc. He is on the Board of Directors at Semnur, Inc. Dr. Lissin was previously employed as a Vice President-Clinical Development by XenoPort, Inc. He received his doctorate degree from Russian National Research Medical University.
Aktive Positionen von Dmitri V. Lissin
| Unternehmen | Position | Beginn |
|---|---|---|
| SCILEX HOLDING COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Semnur, Inc.
 Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2019 |
Ehemalige bekannte Positionen von Dmitri V. Lissin
| Unternehmen | Position | Ende |
|---|---|---|
| XENOPORT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2015 |
Ausbildung von Dmitri V. Lissin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Semnur, Inc.
Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Russian National Research Medical University
 Russian National Research Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
